Monthly Archives: November 2013

                        
                            

Avedro Announces FDA Priority Review Status for Corneal Cross-linking New Drug Application

             
Avedro Announces FDA Priority Review Status for Corneal Cross-linking New Drug Application
               
                   

Avedro Announces FDA Priority Review Status! – Corneal Cross-linking! This is huge news for the keratoconic community. The priority review status for the New Drug Application (NDA) places the application action date at March 15th, 2014.

Read More                
               
           
                               
request a free consultation
request appointment
contact us